Skip to content
Home/Companies/Healthcare/Skyepharma
Skyepharma

Skyepharma

Healthcare·France·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Skyepharma?

Skyepharma is currently owned by Jadel through Jadel Evergreen (2021 vintage), since 2021.

Hand-verified · updated 2026-04-21

Jadel
Investor
Jadel
Jadel Evergreen · 2021 · Evergreen

Key facts

HQFrance
SectorHealthcare
Websitewww.skyepharma.com

More from Jadel Evergreen

Other portfolio companies in the same fund.

CNS Communications
CNS Communications
Active
IT ServicesFrance· 2025
ATA Electronics
Active
IndustrialsFrance· 2024
Isore
Isore
Active
Real EstateFrance· 2023
Reynaud & Fils
Reynaud & Fils
Active
ConsumerFrance· 2023
Ceetal
Active
Business ServicesFrance· 2022
Gagnepark
Active
Real EstateFrance· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Skyepharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Skyepharma?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Skyepharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue